News
IBA AWARD
Every year, IBA offers a scientific award for the best paper or abstract published in a scientific journal, proceedings of […]
See more
IBA Reports Full Year 2021 Results
STRONG ORDER INTAKE AND RECORD BACKLOG WITH PROFITABILITY ACROSS ALL BUSINESS LINES SOLID BALANCE SHEET WITH EUR 130 MILLION NET CASH […]
See more
Newsletter 28
Our Newsletter is out! Read it to discover all the latest market information. Read the Newsletter
See more
FY21 TRADING UPDATE
PROFITABILITY ACROSS ALL BUSINESS LINES Louvain-la-Neuve, Belgium, 1 February 2022 - IBA (Ion Beam Applications SA), the world leader in […]
See more
IBA Launches Compact Low-Energy Cyclotron, Cyclone® KEY
New accelerator provides increased access to diagnosis solutions and enables in-house production of radiopharmaceuticals Louvain-la-Neuve, Belgium, 26 January 2022 […]
See more
Already the 6th Cyclone® KIUBE Rigging in China this year!
The Cyclone® KIUBE has been placed into its final position at HIC in Changshu, China. The new radiopharmacy will produce […]
See more
Installation of the Cyclone® 70 at IBS
After one week of rigging, the installation of the Cyclone® 70P for the Institute of Basic Science (IBS) has now […]
See more
IBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)
Louvain-La-Neuve, Belgium, and BELOIT, Wis., USA November 18, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in […]
See more
IBA BUSINESS UPDATE – THIRD QUARTER 2021
Louvain-La-Neuve, Belgium, November 18, 2021 –IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces […]
See more